Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency

NCT00407472 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.

NCT NCT00407472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency
Lead sponsor
EMD Serono
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2005
Enrollment
38
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy